Predict chances for a successful transfer and pregnancy
ReceptivaDX is a first of its kind test for the detection of BCL6. High levels of BCL6 indicates inflammation usually associated with endometriosis, limiting the ability of an embryo to stick to the endometrial lining.
Patients testing positive for ReceptivaDX are 5 times less likely to succeed in IVF than patients testing negative. If a patient tests positive and endometriosis is suspected, it can then be treated by your physician to increase your chances of success. A negative BCL6 result provides reassurance to patients that endometriosis is not of concern.
For more information about ReceptivaDX, please contact our patient care advocate.